Clinical Trial Update: A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus [Phase 3]

View source ↗

Summary

Nipocalimab is being studied in a Phase 3 trial for adults with moderate to severe systemic lupus erythematosus and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Nipocalimab (nipocalimab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Lupus Erythematosus, Systemic | Phase 3 | Status: RECRUITING